MAM
TCRR
MPM Asset Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,050,865
| Closed | -$6.08M | – | 9 |
|
|
2023
Q1 | $6.08M | Hold |
4,050,865
| – | – | 2.53% | 7 |
|
|
2022
Q4 | $4.05M | Hold |
4,050,865
| – | – | 1.69% | 7 |
|
|
2022
Q3 | $7.29M | Hold |
4,050,865
| – | – | 2.78% | 7 |
|
|
2022
Q2 | $11.7M | Hold |
4,050,865
| – | – | 4.96% | 7 |
|
|
2022
Q1 | $11.2M | Hold |
4,050,865
| – | – | 3.82% | 8 |
|
|
2021
Q4 | $18.9M | Hold |
4,050,865
| – | – | 4.08% | 8 |
|
|
2021
Q3 | $34.5M | Hold |
4,050,865
| – | – | 7.99% | 5 |
|
|
2021
Q2 | $66.5M | Hold |
4,050,865
| – | – | 12.36% | 5 |
|
|
2021
Q1 | $89.4M | Hold |
4,050,865
| – | – | 17.28% | 2 |
|
|
2020
Q4 | $125M | Hold |
4,050,865
| – | – | 17.73% | 2 |
|
|
2020
Q3 | $82.3M | Hold |
4,050,865
| – | – | 15.35% | 4 |
|
|
2020
Q2 | $62.2M | Hold |
4,050,865
| – | – | 18.51% | 3 |
|
|
2020
Q1 | $31.4M | Hold |
4,050,865
| – | – | 19.07% | 3 |
|
|
2019
Q4 | $57.8M | Hold |
4,050,865
| – | – | 25.46% | 2 |
|
|
2019
Q3 | $60.9M | Hold |
4,050,865
| – | – | 26.06% | 3 |
|
|
2019
Q2 | $58M | Hold |
4,050,865
| – | – | 23.42% | 3 |
|
|
2019
Q1 | $70.6M | Buy |
+4,050,865
| New | +$70.6M | 29.11% | 2 |
|